Charlene S. Dezzutti

3.9k total citations
106 papers, 2.8k citations indexed

About

Charlene S. Dezzutti is a scholar working on Infectious Diseases, Virology and Microbiology. According to data from OpenAlex, Charlene S. Dezzutti has authored 106 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Infectious Diseases, 52 papers in Virology and 42 papers in Microbiology. Recurrent topics in Charlene S. Dezzutti's work include HIV Research and Treatment (51 papers), HIV/AIDS Research and Interventions (51 papers) and Reproductive tract infections research (40 papers). Charlene S. Dezzutti is often cited by papers focused on HIV Research and Treatment (51 papers), HIV/AIDS Research and Interventions (51 papers) and Reproductive tract infections research (40 papers). Charlene S. Dezzutti collaborates with scholars based in United States, United Kingdom and South Africa. Charlene S. Dezzutti's co-authors include Lisa C. Rohan, Patricia C. Guenthner, Marilyn Cost, Bernard J. Moncla, Renu B. Lal, James E. Cummins, Sharon L. Hillier, W. Evan Secor, Craig W. Hendrix and Lynn Paxton and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Charlene S. Dezzutti

106 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charlene S. Dezzutti United States	29	1.4k	1.2k	1.1k	697	622	106	2.8k
Guido Vanham Belgium	30	1.1k 0.8×	1.2k 1.0×	504 0.5×	546 0.8×	1.2k 1.9×	86	3.1k
Gilda Tachedjian Australia	37	1.9k 1.4×	1.6k 1.4×	1.4k 1.2×	1.3k 1.9×	600 1.0×	108	4.5k
Charu Kaushic Canada	34	592 0.4×	713 0.6×	1.1k 1.0×	1.2k 1.8×	1.9k 3.0×	91	3.8k
Jo‐Ann S. Passmore South Africa	34	823 0.6×	770 0.7×	1.6k 1.5×	1.3k 1.9×	986 1.6×	119	3.4k
Katharine J Looker United Kingdom	20	660 0.5×	395 0.3×	510 0.5×	2.3k 3.3×	456 0.7×	39	3.2k
Patricia C. Guenthner United States	16	557 0.4×	659 0.6×	525 0.5×	348 0.5×	291 0.5×	28	1.3k
Ian McGowan United States	33	2.2k 1.6×	1.6k 1.4×	726 0.7×	1.3k 1.9×	484 0.8×	132	3.5k
Gregory T. Spear United States	41	1.0k 0.8×	1.6k 1.4×	1.8k 1.7×	1.6k 2.3×	2.0k 3.2×	124	5.0k
J. Gerardo Garcı́a-Lerma United States	31	2.5k 1.9×	2.2k 1.9×	344 0.3×	810 1.2×	175 0.3×	92	3.0k
Adam Burgener Canada	24	654 0.5×	721 0.6×	957 0.9×	671 1.0×	574 0.9×	73	2.3k

Countries citing papers authored by Charlene S. Dezzutti

Since Specialization

Citations

This map shows the geographic impact of Charlene S. Dezzutti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlene S. Dezzutti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlene S. Dezzutti more than expected).

Fields of papers citing papers by Charlene S. Dezzutti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charlene S. Dezzutti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlene S. Dezzutti. The network helps show where Charlene S. Dezzutti may publish in the future.

Co-authorship network of co-authors of Charlene S. Dezzutti

This figure shows the co-authorship network connecting the top 25 collaborators of Charlene S. Dezzutti. A scholar is included among the top collaborators of Charlene S. Dezzutti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charlene S. Dezzutti. Charlene S. Dezzutti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cranston, Ross, Charlene S. Dezzutti, Nicola Richardson‐Harman, et al.. (2019). A Multiple Dose Phase 1 Assessment of Rilpivirine Long Acting in a Model of Preexposure Prophylaxis Against HIV. AIDS Research and Human Retroviruses. 35(9). 794–804. 8 indexed citations

Hughes, Sean M., April L. Ferre, Chris A. R. Baker, et al.. (2018). Cryopreservation of human mucosal tissues. PLoS ONE. 13(7). e0200653–e0200653. 13 indexed citations

Wang, Linlin, Charlene S. Dezzutti, Charles E. Isaacs, et al.. (2018). Vaginal Product Formulation Alters the Innate Antiviral Activity and Glycome of Cervicovaginal Fluids with Implications for Viral Susceptibility. ACS Infectious Diseases. 4(11). 1613–1622. 10 indexed citations

Dezzutti, Charlene S., et al.. (2017). Heterogeneity of HIV-1 Replication in Ectocervical and Vaginal Tissue Ex Vivo. AIDS Research and Human Retroviruses. 34(2). 185–192. 5 indexed citations

Richardson‐Harman, Nicola, Peter A. Anton, Ian McGowan, et al.. (2016). Analytical Advances in the Ex Vivo Challenge Efficacy Assay. AIDS Research and Human Retroviruses. 33(4). 395–403. 14 indexed citations

Zhou, Tianhua, et al.. (2016). The Effect of Commonly Used Excipients on the Epithelial Integrity of Human Cervicovaginal Tissue. AIDS Research and Human Retroviruses. 32(10-11). 992–1004. 9 indexed citations

Ham, Anthony S., Jennifer J. Peters, David F. Katz, et al.. (2015). The rational design and development of a dual chamber vaginal/rectal microbicide gel formulation for HIV prevention. Antiviral Research. 120. 153–164. 21 indexed citations

McGowan, Ian, Ross Cranston, Cindy Jacobson, et al.. (2015). A Phase 1 Randomized, Open Label, Rectal Safety, Acceptability, Pharmacokinetic, and Pharmacodynamic Study of Three Formulations of Tenofovir 1% Gel (the CHARM-01 Study). PLoS ONE. 10(5). e0125363–e0125363. 49 indexed citations

Cohen, Jessica, et al.. (2015). Assessing the potential of the Woman’s Condom for vaginal drug delivery. Contraception. 92(3). 254–260. 6 indexed citations

10.

Dezzutti, Charlene S., et al.. (2014). Expression, Activity, and Regulation of Phosphorylating Enzymes in Genital and Colorectal Tissues and Immune Cells. AIDS Research and Human Retroviruses. 30(S1). A59–A59. 1 indexed citations

11.

Schwartz, Jill L., Debra H. Weiner, Angela D. M. Kashuba, et al.. (2014). Multicompartmental Pharmacokinetics of Tenofovir 1% Gel Using the BAT 24 Regimen Versus Daily and Single Pericoital Dosing. AIDS Research and Human Retroviruses. 30(S1). A37–A37. 3 indexed citations

12.

McGowan, Ian, Charlene S. Dezzutti, Nicola Richardson‐Harman, et al.. (2014). A Phase 1 Open Label Safety, Acceptability, Pharmacokinetic, and Pharmacodynamic Study of Intramuscular TMC278 LA (the MWRI-01 Study). AIDS Research and Human Retroviruses. 30(S1). A71–A71. 4 indexed citations

13.

Mauck, Christine K., Debra H. Weiner, Neelima Chandra, et al.. (2013). Toward Early Safety Alert Endpoints: Exploring Biomarkers Suggestive of Microbicide Failure. AIDS Research and Human Retroviruses. 29(11). 1475–1486. 15 indexed citations

14.

Cummins, James E., Maxine M. Denniston, Kenneth H. Mayer, et al.. (2007). Mucosal Innate Immune Factors in Secretions from High-Risk Individuals Immunized with a Bivalent gp120 Vaccine. AIDS Research and Human Retroviruses. 23(5). 748–754. 4 indexed citations

15.

Cummins, James E., Timothy J. Bush, Zhiwei Wu, et al.. (2006). Mucosal Innate Immune Factors in the Female Genital Tract Are Associated with Vaginal HIV-1 Shedding Independent of Plasma Viral Load. AIDS Research and Human Retroviruses. 22(8). 788–795. 51 indexed citations

16.

Guenthner, Patricia C., W. Evan Secor, & Charlene S. Dezzutti. (2005). Trichomonas vaginalis -Induced Epithelial Monolayer Disruption and Human Immunodeficiency Virus Type 1 (HIV-1) Replication: Implications for the Sexual Transmission of HIV-1. Infection and Immunity. 73(7). 4155–4160. 110 indexed citations

17.

Swords, W. Edward, Patricia C. Guenthner, K A Birkness, et al.. (2005). Mycobacterium xenopi multiplies within human macrophages and enhances HIV replication in vitro. Microbial Pathogenesis. 40(2). 41–47. 7 indexed citations

18.

Sriwanthana, Busarawan, Thomas Hodge, Timothy D. Mastro, et al.. (2001). HIV-Specific Cytotoxic T Lymphocytes, HLA-A11, and Chemokine-Related Factors May Act Synergistically to Determine HIV Resistance in CCR5 Δ32-Negative Female Sex Workers in Chiang Rai, Northern Thailand. AIDS Research and Human Retroviruses. 17(8). 719–734. 71 indexed citations

19.

Dezzutti, Charlene S., Donna L. Rudolph, & R. B. Lal. (1995). Infection with human T-lymphotropic virus types I and II results in alterations of cellular receptors, including the up-modulation of T-cell counterreceptors CD40, CD54, and CD80 (B7-1). Clinical and Diagnostic Laboratory Immunology. 2(3). 349–355. 16 indexed citations

20.

Toedter, Gary, Samuel Pearlman, James R. Blakeslee, et al.. (1992). Development of a Monoclonal Antibody-Based p24 Capsid Antigen Detection Assay for HTLV-I, HTLV-II, and STLV-I Infection. AIDS Research and Human Retroviruses. 8(4). 527–532. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact